Avience Biomedicals Stock Price Analysis and Quick Research Report. Is Avience Biomedicals an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Avience Biomedicals. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Avience Biomedicals has a PE ratio of 29.5562819115982 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Avience Biomedicals has ROA of 14.8342% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Avience Biomedicals has a Current ratio of 1.3989.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Avience Biomedicals has a ROE of 38.643%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Avience Biomedicals has a Debt to Equity ratio of 0.6698 which means that the company has low proportion of debt in its capital.

• Sales growth: Avience Biomedicals has reported revenue growth of 77.7258% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Avience Biomedicals for the current financial year is 26.5833607365998%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Avience Biomedicals is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Avience Biomedicals is Rs 9.3618. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Avience Biomedicals in Ticker for free. Also, one can get the intrinsic value of Avience Biomedicals by using Valuation Calculators, which are available with a Finology ONE subscription. 

Avience Biomedicals FAQs

Q1. What is Avience Biomedicals share price today?
Ans: The current share price of Avience Biomedicals is Rs 276.7.

Q2. What is the market capitalisation of Avience Biomedicals?
Ans: Avience Biomedicals has a market capitalisation of Rs 151.77149952 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Avience Biomedicals?
Ans: The PE ratio of Avience Biomedicals is 29.5562819115982 and the P/B ratio of Avience Biomedicals is 2.98986449981631, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Avience Biomedicals share?
Ans: The 52-week high share price of Avience Biomedicals is Rs 414.95, and the 52-week low share price of Avience Biomedicals is Rs 276.4.

Q5. Does Avience Biomedicals pay dividends?
Ans: Currently, Avience Biomedicals does not pay dividends. Dividend yield of Avience Biomedicals is around 0%.

Q6. What are the face value and book value of Avience Biomedicals shares?
Ans: The face value of Avience Biomedicals shares is Rs 10, while the book value per share of Avience Biomedicals is around Rs 92.546. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Avience Biomedicals?
Ans: Avience Biomedicals has a total debt of Rs 13.7468 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Avience Biomedicals?
Ans: The ROE of Avience Biomedicals is 38.643% and ROCE of Avience Biomedicals is 31.6342%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Avience Biomedicals a good buy for the long term?
Ans: The Avience Biomedicals long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Avience Biomedicals undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Avience Biomedicals appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Avience Biomedicals’s financials?
Ans: You can review Avience Biomedicals’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.